Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 11. April 2026
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2188  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 43744  
   
Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future Perspectives.
Neurol Ther
Preziosa P, Guido G, Filippi M, Rocca MA.
PMID: 41961242 [PubMed - as supplied by publisher]


Exploring the Effects of Remotely Supervised Transcranial Direct Current Stimulation on Motor Outcomes in Multiple Sclerosis: A Systematic Review.
NeuroRehabilitation
Aljuhni R, Almotiri H, Albishi A, Abualait T.
PMID: 41960941 [PubMed - as supplied by publisher]


"Investigating Predictive Associations Among Postural Balance, Functional Mobility, Cognitive Function and Psychological Well-Being in Patients With Multiple Sclerosis: A Cross-Sectional Study".
Physiother Res Int
Darwesh AAA, Batarfi RM, Abdelmohsen AM, Hegazy RM.
PMID: 41960734 [PubMed - indexed for MEDLINE]


Diagnosis of Multiple Sclerosis Using Multimodal Deep Learning Integrating Lesion and Normal-Appearing White Matter: A Retrospective Study with International Multicentre External Validation.
medRxiv
Ma J, Stepanov V, Rui W, Chen HC, Lis M, Stanek A, Puto T, Lan M, Chen J, Liu T, Patel R, Breen M, Lee M, Eikermann-Haerter K, Shepherd TM, Novikov DS, O'Neill KA, Fieremans E, Shen Y.
PMID: 41959762 [PubMed]


Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes.
Ther Adv Neurol Disord
Ziccardi S, Marastoni D, Biasi P, Tamanti A, Pizzini FB, Calderone M, Camera V, Bertolazzo M, Daldosso A, Milocco B, Magliozzi R, Calabrese M.
PMID: 41958532 [PubMed]


Comparing the Effect of Semi-Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial.
Ann Clin Transl Neurol
Maggio MG, Latella D, Bonanno L, Dos Santos PCR, Maldonado-Díaz M, Plotnik M, De Luca R, Quartarone A, Calabrò RS.
PMID: 41958443 [PubMed - as supplied by publisher]


The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study.
J Neurol
Hegen H, Föttinger F, Walde J, Berek K, Martinez-Serrat M, Damulina A, Krajnc N, Ponleitner M, Di Pauli F, Enzinger C, Deisenhammer F, Berger T, Khalil M, Bsteh G, Austrian Multiple Sclerosis Database Study group.
PMID: 41957324 [PubMed - indexed for MEDLINE]


Mechanistic insights into Nicotine-derived nitrosamine ketone (NNK) in multiple sclerosis via integrated systems analyses.
Gene
Xiao X, Cui T, Hu S, Shen S, Huang Y, Cui C, Tan H, Qiu W, Zhao Y.
PMID: 41956308 [PubMed - as supplied by publisher]


Diet and multiple sclerosis: Behaviour change techniques in the digital health application levidex.
Patient Educ Couns
Krause N, Glasenapp BV, Heesen C, Meyer B, Riemann-Lorenz K.
PMID: 41955893 [PubMed - as supplied by publisher]


Twelve-week intermittent hypoxia intervention in multiple sclerosis - A safety and feasibility trial.
Mult Scler Relat Disord
Schubert C, Suling A, Ramien C, Bier J, Reinhardt S, Silemek ACH, Raich L, Kuhle J, Ameismeier T, Böld T, Heelemann S, Zapf A, Häußler V, Stellmann JP, Heesen C, Friese MA, Rosenkranz SC.
PMID: 41955667 [PubMed - as supplied by publisher]


Coping and benefit seeking as determinants of health-related quality of life in multiple sclerosis: a cross-sectional study.
Psychol Health Med
Sarabia Montaño V, Ubillos Landa S, González Castro JL.
PMID: 41955455 [PubMed - as supplied by publisher]


Aberrant long-chain fatty acids metabolism and its interplay with immuno-inflammatory responses in relapsing-remitting multiple sclerosis.
Front Immunol
Zhu XX, Wang PJ, Liu HX, Sun P, Yu LM, Yang F.
PMID: 41953040 [PubMed - indexed for MEDLINE]


Iron accumulation in the corpus callosum: a quantitative MRI study in relapsing-remitting multiple sclerosis.
Ir J Med Sci
Al-Radaideh A, Almuqbel MM, Abousrafa S, Radaideh A, Hbahbih M.
PMID: 41951920 [PubMed - as supplied by publisher]


The effects of probiotics supplementation on serum markers of oxidative stress in relapsing-remitting multiple sclerosis: a randomised, double-blind, placebo-controlled clinical trial.
Benef Microbes
Mohy N, Sanaie S, Rahnemayan S, Yousefi M, Talebi M, Naseri A.
PMID: 41951219 [PubMed - as supplied by publisher]


The effect of resistance training on quality of life in people with multiple sclerosis: A systematic review, meta-analysis, and meta-regression.
Am J Med
Ashworth H, Sanal-Hayes NE, Sculthorpe NF, Hendrickse PW, Gaffney CJ, Chan AM, Hayes LD.
PMID: 41950981 [PubMed - as supplied by publisher]


An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.
J Neurol
Jarius S, Ruprecht K, Metz I, König FB, Haas J, Brück W, Paul F, Wildemann B.
PMID: 41949651 [PubMed - indexed for MEDLINE]


HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis.
Front Immunol
Ruberto S, Dominguez-Mozo MI, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Casanova-Peño I, González-Suárez I, Garcia-Martinez MA, Arroyo R, Alvarez-Lafuente R.
PMID: 41948318 [PubMed - indexed for MEDLINE]


Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosis.
BMJ Neurol Open
Staniki, Steinemann N, López-Alcalde J, Canella C, Barth J, Chan A, Roth P, Calabrese P, Zecca C, Gobbi C, Manjaly ZM, Ammann S, Kägi S, Baum C, Kamm CP, Puhan MA, Witt CM, von Wyl V, Swiss Multiple Sclerosis Registry.
PMID: 41948090 [PubMed]


Adjunctive strategies in multiple sclerosis treatment: non-pharmacological approaches and their potential clinical implications.
J Transl Med
Wang Y, Yan W, Yao L, Liu W, Yin Z, Xiao L, Niu J.
PMID: 41947223 [PubMed - as supplied by publisher]


Salivary cortisol as a neuroendocrine stress biomarker for xerostomia in multiple sclerosis patients: a comparative cross-sectional study.
BMC Oral Health
Khabazian T, Khabazian A, Saleh MHA, Samavatijame F, Mohammadi S, Koopaie M.
PMID: 41947123 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 43744    Seite 1 von 2188  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1